Journal
BIOMOLECULES
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/biom11030425
Keywords
SARS-CoV-2; rapid antigen test; point of entry; Italy
Categories
Funding
- Ministero della Salute [COVID-2020-12371817]
- European Commission-Horizon 2020 (EU) [101003544-CoNVat, 101005111-DECISION, 101005075-KRONO]
- European Virus Archive-GLOBAL [653316, 871029]
- Regional Reference Laboratory
- Lazio Region Health Authority
Ask authors/readers for more resources
The COVID-19 pandemic poses a significant global challenge, highlighting the urgent need to enhance testing capacity. Rapid Antigen Tests are effective in identifying infected individuals at points of entry to help control virus spread. This approach is crucial for areas where molecular testing is not readily available, supporting important public health strategies.
COVID-19 pandemic is a dramatic health, social and economic global challenge. There is urgent need to maximize testing capacity. Rapid Antigen Tests (RAT) represent good candidates for point-of-care and mass surveillance testing to rapidly identify SARS-CoV-2-infected people, counterbalancing lower sensitivity vs. gold standard molecular tests with fast results and possible recurrent testing. We describe the results obtained with the testing algorithm implemented at points of entry (airports and ports) in the Lazio Region (Italy), using the STANDARD F COVID-19 Antigen Fluorescence ImmunoAssay (FIA), followed by molecular confirmation of FIA-positive samples. From mid-August to mid-October 2020, 73,643 RAT were reported to the Regional Surveillance Information System for travelers at points of entry in Lazio Region. Of these, 1176 (1.6%) were FIA-positive, and the proportion of RT-PCR-confirmed samples was 40.5%. Our data show that the probability of confirmation was directly dependent from the semi-quantitative FIA results. In addition, the molecularly confirmed samples were those with high levels of virus and that were actually harboring infectious virus. These results support public health strategies based on early mass screening campaigns by RAT in settings where molecular testing is not feasible or easily accessible, such as points of entry. This approach would contribute to promptly controlling viral spread through travel, which is now of particular concern due to the spread of SARS-CoV-2 variants.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available